Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Iranzo

Showing results (671-680 of 735) with videos related to

Pageof 74
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 25, 2024
Locus coeruleus integrity and neuropsychiatric symptoms in a cohort of early- and late-onset Alzheimer's diseaseNeus Falgàs, Marta Peña-González, Andrea Val-Guardiola, et al.
Med (New York, N.Y.)|September 12, 2024
The DEBBRAH trial: Trastuzumab deruxtecan in HER2-positive and HER2-low breast cancer patients with leptomeningeal carcinomatosisMarta Vaz Batista, José Manuel Pérez-García, Laia Garrigós, et al.
Breast Cancer Research : BCR|November 12, 2020
Immuno-priming durvalumab with bevacizumab in HER2-negative advanced breast cancer: a pilot clinical trialMiguel Quintela-Fandino, Esther Holgado, Luis Manso, et al.
Neurology|April 7, 2017
Clinical manifestations of the anti-IgLON5 diseaseCarles Gaig, Francesc Graus, Yarko Compta, et al.
Alimentary Pharmacology & Therapeutics|February 8, 2024
An algorithm based on immunotherapy discontinuation and liver biopsy spares corticosteroids in two thirds of cases of severe checkpoint inhibitor-induced liver injuryMar Riveiro-Barciela, Ana Barreira-Díaz, María-Teresa Salcedo, et al.
Blood Cancer Journal|January 11, 2025
Diverse real-life outcomes after intensive risk-adapted therapy for 1034 AML patients from the CETLAM GroupGuadalupe Oñate, Ana Garrido, Montserrat Arnan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2025
Second-Line Endocrine Therapy With or Without Palbociclib Rechallenge in Patients With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: PALMIRA TrialAntonio Llombart-Cussac, Catherine Harper-Wynne, Antonia Perelló, et al.
Annals of Neurology|March 14, 2015
Risk factors for neurodegeneration in idiopathic rapid eye movement sleep behavior disorder: a multicenter studyRonald B Postuma, Alex Iranzo, Birgit Hogl, et al.
Sleep|October 25, 2021
Video-polysomnography procedures for diagnosis of rapid eye movement sleep behavior disorder (RBD) and the identification of its prodromal stages: guidelines from the International RBD Study GroupMatteo Cesari, Anna Heidbreder, Erik K St Louis, et al.
Journal of Fungi (Basel, Switzerland)|December 24, 2025
Invasive <i>Trichosporon</i> Infection in Solid Organ Transplant Recipients: A Single-Center Experience in Madrid, SpainAntonio Ramos-Martínez, Oscar Zaragoza, Andrea Gutiérrez-Villanueva, et al.
Pageof 74

Showing results (671-680 of 735) with videos related to

Sort By:
Pageof 74
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 25, 2024
Locus coeruleus integrity and neuropsychiatric symptoms in a cohort of early- and late-onset Alzheimer's diseaseNeus Falgàs, Marta Peña-González, Andrea Val-Guardiola, et al.
Med (New York, N.Y.)|September 12, 2024
The DEBBRAH trial: Trastuzumab deruxtecan in HER2-positive and HER2-low breast cancer patients with leptomeningeal carcinomatosisMarta Vaz Batista, José Manuel Pérez-García, Laia Garrigós, et al.
Breast Cancer Research : BCR|November 12, 2020
Immuno-priming durvalumab with bevacizumab in HER2-negative advanced breast cancer: a pilot clinical trialMiguel Quintela-Fandino, Esther Holgado, Luis Manso, et al.
Neurology|April 7, 2017
Clinical manifestations of the anti-IgLON5 diseaseCarles Gaig, Francesc Graus, Yarko Compta, et al.
Alimentary Pharmacology & Therapeutics|February 8, 2024
An algorithm based on immunotherapy discontinuation and liver biopsy spares corticosteroids in two thirds of cases of severe checkpoint inhibitor-induced liver injuryMar Riveiro-Barciela, Ana Barreira-Díaz, María-Teresa Salcedo, et al.
Blood Cancer Journal|January 11, 2025
Diverse real-life outcomes after intensive risk-adapted therapy for 1034 AML patients from the CETLAM GroupGuadalupe Oñate, Ana Garrido, Montserrat Arnan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2025
Second-Line Endocrine Therapy With or Without Palbociclib Rechallenge in Patients With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: PALMIRA TrialAntonio Llombart-Cussac, Catherine Harper-Wynne, Antonia Perelló, et al.
Annals of Neurology|March 14, 2015
Risk factors for neurodegeneration in idiopathic rapid eye movement sleep behavior disorder: a multicenter studyRonald B Postuma, Alex Iranzo, Birgit Hogl, et al.
Sleep|October 25, 2021
Video-polysomnography procedures for diagnosis of rapid eye movement sleep behavior disorder (RBD) and the identification of its prodromal stages: guidelines from the International RBD Study GroupMatteo Cesari, Anna Heidbreder, Erik K St Louis, et al.
Journal of Fungi (Basel, Switzerland)|December 24, 2025
Invasive <i>Trichosporon</i> Infection in Solid Organ Transplant Recipients: A Single-Center Experience in Madrid, SpainAntonio Ramos-Martínez, Oscar Zaragoza, Andrea Gutiérrez-Villanueva, et al.
Pageof 74